185 related articles for article (PubMed ID: 37716465)
21. Differences in Cancer-Specific Mortality of Right- Versus Left-Sided Colon Adenocarcinoma: A Surveillance, Epidemiology, and End Results Database Analysis.
Wang C; Wainberg ZA; Raldow A; Lee P
JCO Clin Cancer Inform; 2017 Nov; 1():1-9. PubMed ID: 30657397
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study.
Beltrán L; González-Trejo S; Carmona-Herrera DD; Carrillo JF; Herrera-Goepfert R; Aiello-Crocifoglio V; Gallardo-Rincón D; Meléndez-Ponce NA; Ochoa-Carrillo FJ; Oñate-Ocaña LF
Arch Med Res; 2019 Feb; 50(2):63-70. PubMed ID: 31349955
[TBL] [Abstract][Full Text] [Related]
23. Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients.
Popławski P; Tohge T; Bogusławska J; Rybicka B; Tański Z; Treviño V; Fernie AR; Piekiełko-Witkowska A
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):744-752. PubMed ID: 28012969
[TBL] [Abstract][Full Text] [Related]
24. Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer.
Yi T; Zhang Y; Ng DM; Xi Y; Ye M; Cen L; Li J; Fan X; Li Y; Hu S; Rong H; Xie Y; Zhao G; Chen L; Chen C; Ni S; Mi J; Dai X; Liao Q
Front Oncol; 2021; 11():685515. PubMed ID: 34211853
[TBL] [Abstract][Full Text] [Related]
25. Molecular heterogeneity of guanine nucleotide binding-protein γ subunit 4 in left- and right-sided colon cancer.
Song J; Yang J; Lin R; Cai X; Zheng L; Chen Y
Oncol Lett; 2020 Dec; 20(6):334. PubMed ID: 33123245
[TBL] [Abstract][Full Text] [Related]
26. Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study.
Hamfjord J; Myklebust TÅ; Larsen IK; Kure EH; Glimelius B; Guren TK; Tveit KM; Guren MG
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):342-351. PubMed ID: 34853022
[TBL] [Abstract][Full Text] [Related]
27. Analysis of multi-omics differences in left-side and right-side colon cancer.
Huang Y; Duanmu J; Liu Y; Yan M; Li T; Jiang Q
PeerJ; 2021; 9():e11433. PubMed ID: 34026368
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinicopathological and survival features of right and left colon cancers.
Helvaci K; Eraslan E; Yildiz F; Tufan G; Demirci U; Berna Oksuzoglu O; Yalcintas Arslan U
J BUON; 2019; 24(5):1845-1851. PubMed ID: 31786846
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of circulating immune cells in left- and right-sided colon cancer.
Di J; Zhuang M; Yang H; Jiang B; Wang Z; Su X
PeerJ; 2017; 5():e4153. PubMed ID: 29230377
[TBL] [Abstract][Full Text] [Related]
30. Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma.
Chen WJ; Dong KQ; Pan XW; Gan SS; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Zhou W; Rini B; Cui XG
Cell Death Dis; 2023 Jan; 14(1):30. PubMed ID: 36646679
[TBL] [Abstract][Full Text] [Related]
31. High Oct4 predicted worse prognosis of right-sided colon cancer patients.
Wang QH; Zhang M; Shi CT; Xie JJ; Chen F; Shi QF; Cheng J; Wang HN
Future Oncol; 2018 Sep; 14(22):2279-2291. PubMed ID: 29656661
[TBL] [Abstract][Full Text] [Related]
32. Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis.
Peng Q; Lin K; Chang T; Zou L; Xing P; Shen Y; Zhu Y
Onco Targets Ther; 2018; 11():609-618. PubMed ID: 29430186
[TBL] [Abstract][Full Text] [Related]
33. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
[TBL] [Abstract][Full Text] [Related]
34. Whether regional lymph nodes evaluation should be equally required for both right and left colon cancer.
Guan X; Chen W; Liu Z; Jiang Z; Hu H; Zhao Z; Wang S; Chen Y; Wang G; Wang X
Oncotarget; 2016 Sep; 7(37):59945-59956. PubMed ID: 27494866
[TBL] [Abstract][Full Text] [Related]
35. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis.
Nitsche U; Stögbauer F; Späth C; Haller B; Wilhelm D; Friess H; Bader FG
Dig Surg; 2016; 33(2):157-63. PubMed ID: 26824772
[TBL] [Abstract][Full Text] [Related]
36. Oncological impact of vascular invasion in colon cancer might differ depending on tumor sidedness.
Shalkamy MSA; Bae JH; Lee CS; Han SR; Kim JH; Kye BH; Lee IK; Lee YS
J Minim Invasive Surg; 2022 Jun; 25(2):53-62. PubMed ID: 35821690
[TBL] [Abstract][Full Text] [Related]
37. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
38. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC
J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208
[TBL] [Abstract][Full Text] [Related]
39. A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning.
Wang Z; Xu C; Liu W; Zhang M; Zou J; Shao M; Feng X; Yang Q; Li W; Shi X; Zang G; Yin C
Front Endocrinol (Lausanne); 2022; 13():1083569. PubMed ID: 36686417
[TBL] [Abstract][Full Text] [Related]
40. Differences in clinical features and oncologic outcomes between metastatic right and left colon cancer.
Kim K; Kim YW; Shim H; Kim BR; Kwon HY
J BUON; 2018 Dec; 23(7):11-18. PubMed ID: 30722106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
